Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share, Industry Growth, Trend, Drivers, Challenges, Key Companies by 2026
The global idiopathic thrombocytopenic Purpura therapeutics market is governed by drugs that suppress the immune system, injections that increase blood count, and drugs that boost platelet production. Association of idiopathic thrombocytopenic Purpura with other infections such as H. pylori infection and others related to immunosuppressant favors market for idiopathic thrombocytopenic Purpura therapeutics. In spite of the low global incidence of idiopathic thrombocytopenic Purpura, its fatal and serious complications have led to advancement in its treatment contributing to the growth of the idiopathic...
View full press release